Live symbol workspace

MA market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $493.44

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$468.77

Resistance

$518.11

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$493.44

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for MA skewed neutral (4 of 4 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

31%

▼ 2.7 pts vs previous week

Avg confidence across 23 calls in the last 7 days

What sources say

Neutral 4 articles

3 Big Reasons to Love Mastercard (MA)

Vicore Pharma to Commence Trading in the United States on the Nasdaq Stock Market

Odd Lots: Rory Johnston on Why Oil Didn’t Hit $200 (Podcast)

Insider Trading

Insider	Role	Date	Type	Value
Arkell Sandra A	Controller	Jul 07 '26	Sale	108000.0
Arkell Sandra A	Controller	Jul 06 '26	Sale	108000.0
RAJ SESHADRI	Officer	Jul 02 '26	Proposed Sale	1032864.0
Seshadri Raj	Chief Commercial …	Jul 01 '26	Option Exercise	580500.0
Seshadri Raj	Chief Commercial …	Jul 02 '26	Option Exercise	573824.0
Seshadri Raj	Chief Commercial …	Jul 01 '26	Sale	2534700.0
Seshadri Raj	Chief Commercial …	Jul 02 '26	Sale	1047276.0
EDWARD GRUNDE MCLAUGHLIN	Officer	Jul 01 '26	Proposed Sale	7323936.0
RAJ SESHADRI	Officer	Jul 01 '26	Proposed Sale	2568000.0
Ling Hai	President, AP, …	Feb 23 '26	Option Exercise	404189.0

Source: FinViz — Data may be delayed

Technical Observations

Refreshing technical observations from FinViz...

MA News Intelligence (36 articles)

AI-curated news influencing MA price, sentiment, and trend

Explore All MA News with AI Analysis

Economy

2 days, 12 hours ago

3 Big Reasons to Love Mastercard (MA)

Over the last six months, Mastercard’s shares have sunk to $516.69, producing a disappointing 10.9% loss - a stark contrast …

Impact on MA: Neutral market sentiment indicated

Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

1 week, 1 day ago

Vicore Pharma to Commence Trading in the United States on the Nasdaq Stock Market

STOCKHOLM, SE AND CAMBRIDGE, MA / ACCESS Newswire / July 1, 2026 / Vicore Pharma Holding AB (Nasdaq Stockholm:VICO)(Nasdaq US:VCRE), …

Impact on MA: Neutral market sentiment indicated

Analysis of stock market developments showing neutral sentiment. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Global Markets & Finance

1 week, 6 days ago

Odd Lots: Rory Johnston on Why Oil Didn’t Hit $200 (Podcast)

The Strait of Hormuz has (mostly) re-opened! Crude prices are still up since the start of the war with Iran, …

Impact on MA: Neutral market sentiment indicated

Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)

View full analysis →

Bloomberg 50% confidence

Economy

2 weeks, 3 days ago

Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN MATEO, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel …

Impact on MA: Neutral market sentiment indicated

Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Stocks

2 weeks, 6 days ago

Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker

While the market's enthusiasm for one of Zealand's experimental drugs has cooled, investors are shifting focus to amylin-based medicines as …

Impact on MA: Neutral market sentiment indicated

Analysis of stock market developments showing neutral sentiment. Medium (50%)

View full analysis →

CNBC 50% confidence

Economy

3 weeks, 1 day ago

Figma Stock Is Battered, but Citi Sees a Massive Turnaround Ahead

The design-software maker has been battered by fears of artificial intelligence disruption and a broad sector downturn. Figma shares were …

Impact on MA: May pressure downward momentum

Analysis of stock market developments showing bearish sentiment. Medium (60%)

View full analysis →

Yahoo Finance 60% confidence